NCT07338838 2026-01-14
To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Not yet recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Akeso
Shandong New Time Pharmaceutical Co., LTD